ID S4A8_HUMAN Reviewed; 1093 AA. AC Q2Y0W8; A0MMZ1; B4DHY0; E7EML0; F5GZ31; F5H7F5; O94843; O95233; Q004B4; AC Q8N3U2; Q8TC60; Q9UKX8; DT 08-APR-2008, integrated into UniProtKB/Swiss-Prot. DT 20-DEC-2005, sequence version 1. DT 24-JAN-2024, entry version 145. DE RecName: Full=Electroneutral sodium bicarbonate exchanger 1; DE AltName: Full=Electroneutral Na(+)-driven Cl-HCO3 exchanger; DE AltName: Full=Solute carrier family 4 member 8; DE AltName: Full=k-NBC3; GN Name=SLC4A8 {ECO:0000312|EMBL:AAY79176.1, GN ECO:0000312|HGNC:HGNC:11034}; GN Synonyms=KIAA0739, NBC {ECO:0000312|EMBL:AAC82380.1}, NBC3 GN {ECO:0000303|PubMed:10362779}, NDCBE1 {ECO:0000303|PubMed:11133997}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] {ECO:0000305, ECO:0000312|EMBL:AAC82380.1} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, ACTIVITY RP REGULATION (ISOFORM 3), AND TRANSPORTER ACTIVITY (ISOFORM 3). RC TISSUE=Frontal cortex {ECO:0000312|EMBL:AAC82380.1}; RX PubMed=11133997; DOI=10.1074/jbc.c000716200; RA Grichtchenko I.I., Choi I., Zhong X., Bray-Ward P., Russell J.M., RA Boron W.F.; RT "Cloning, characterization, and chromosomal mapping of a human RT electroneutral Na(+)-driven Cl-HCO3 exchanger."; RL J. Biol. Chem. 276:8358-8363(2001). RN [2] {ECO:0000305, ECO:0000312|EMBL:AAY79176.1} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 4 AND 5), ALTERNATIVE SPLICING RP (ISOFORM 3), FUNCTION, TRANSPORTER ACTIVITY (ISOFORMS 1; 3; 4 AND 5), RP ACTIVITY REGULATION (ISOFORMS 1; 3; 4 AND 5), SUBCELLULAR LOCATION RP (ISOFORMS 1; 3; 4 AND 5), AND TISSUE SPECIFICITY (ISOFORMS 1; 4 AND 5). RC TISSUE=Brain {ECO:0000312|EMBL:AAY79176.1}, and Heart RC {ECO:0000312|EMBL:ABJ91577.1}; RX PubMed=18577713; DOI=10.1152/physiolgenomics.90259.2008; RA Parker M.D., Bouyer P., Daly C.M., Boron W.F.; RT "Cloning and characterization of novel human SLC4A8 gene products encoding RT Na+-driven Cl-/HCO3(-) exchanger variants NDCBE-A, -C, and -D."; RL Physiol. Genomics 34:265-276(2008). RN [3] {ECO:0000305, ECO:0000312|EMBL:BAA34459.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Brain {ECO:0000312|EMBL:BAA34459.1}; RX PubMed=9872452; DOI=10.1093/dnares/5.5.277; RA Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A., RA Kotani H., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XI. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 5:277-286(1998). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8). RC TISSUE=Caudate nucleus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7). RC TISSUE=Amygdala; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16541075; DOI=10.1038/nature04569; RA Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., RA Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., RA Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., RA Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., RA Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E., RA Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., RA Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., RA Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., RA Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., RA Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., RA Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., RA Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., RA Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., RA Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., RA Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K., RA Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D., RA Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R., RA David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E., RA D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N., RA Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N., RA Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R., RA Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S., RA LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H., RA Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P., RA Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G., RA Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E., RA Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S., RA Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., RA Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J., RA Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A., RA Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M., RA Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I., RA Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A., RA Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y., RA Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A., RA Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F., RA Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L., RA Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G., RA Gibbs R.A.; RT "The finished DNA sequence of human chromosome 12."; RL Nature 440:346-351(2006). RN [7] {ECO:0000305, ECO:0000312|EMBL:AAY79176.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [8] {ECO:0000305, ECO:0000312|EMBL:AAH25994.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6). RC TISSUE=Testis {ECO:0000312|EMBL:AAH25994.1}; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [9] {ECO:0000305, ECO:0000312|EMBL:AAD52981.1} RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-670 (ISOFORMS 1/3/6), AND TISSUE RP SPECIFICITY. RC TISSUE=Testis carcinoma {ECO:0000269|PubMed:10362779}; RX PubMed=10362779; DOI=10.1152/ajprenal.1999.276.6.f903; RA Amlal H., Burnham C.E., Soleimani M.; RT "Characterization of Na+/HCO-3 cotransporter isoform NBC-3."; RL Am. J. Physiol. 276:F903-F913(1999). RN [10] RP ERRATUM OF PUBMED:10362779. RA Amlal H., Burnham C.E., Soleimani M.; RL Am. J. Physiol. 277:F477-F477(1999). RN [11] {ECO:0000305} RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=17715183; DOI=10.1152/ajpregu.00356.2007; RA Damkier H.H., Nielsen S., Praetorius J.; RT "Molecular expression of SLC4-derived Na+-dependent anion transporters in RT selected human tissues."; RL Am. J. Physiol. 293:R2136-R2146(2007). RN [12] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [13] RP X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 1-344 (ISOFORM 4), SUBUNIT RP (ISOFORM 4), MUTAGENESIS OF TRP-80; HIS-167 AND HIS-169 (ISOFORM 4), RP ZINC-BINDING (ISOFORM 4), AND ACTIVITY REGULATION (ISOFORM 4). RX PubMed=28935959; DOI=10.1038/s41598-017-12409-0; RA Alvadia C.M., Sommer T., Bjerregaard-Andersen K., Damkier H.H., RA Montrasio M., Aalkjaer C., Morth J.P.; RT "The crystal structure of the regulatory domain of the human sodium-driven RT chloride/bicarbonate exchanger."; RL Sci. Rep. 7:12131-12131(2017). CC -!- FUNCTION: Mediates electroneutral sodium- and carbonate-dependent CC chloride-HCO3(-) exchange with a Na(+):HCO3(-) stoichiometry of 2:1 CC (PubMed:18577713). Plays a major role in pH regulation in neurons (By CC similarity). Mediates sodium reabsorption in the renal cortical CC collecting ducts (By similarity). {ECO:0000250|UniProtKB:Q8JZR6, CC ECO:0000269|PubMed:18577713}. CC -!- CATALYTIC ACTIVITY: [Isoform 1]: CC Reaction=chloride(in) + 2 hydrogencarbonate(out) + Na(+)(out) = CC chloride(out) + 2 hydrogencarbonate(in) + Na(+)(in); CC Xref=Rhea:RHEA:72739, ChEBI:CHEBI:17544, ChEBI:CHEBI:17996, CC ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:18577713}; CC -!- CATALYTIC ACTIVITY: [Isoform 3]: CC Reaction=chloride(in) + 2 hydrogencarbonate(out) + Na(+)(out) = CC chloride(out) + 2 hydrogencarbonate(in) + Na(+)(in); CC Xref=Rhea:RHEA:72739, ChEBI:CHEBI:17544, ChEBI:CHEBI:17996, CC ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:11133997, CC ECO:0000269|PubMed:18577713}; CC -!- CATALYTIC ACTIVITY: [Isoform 4]: CC Reaction=chloride(in) + 2 hydrogencarbonate(out) + Na(+)(out) = CC chloride(out) + 2 hydrogencarbonate(in) + Na(+)(in); CC Xref=Rhea:RHEA:72739, ChEBI:CHEBI:17544, ChEBI:CHEBI:17996, CC ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:18577713}; CC -!- CATALYTIC ACTIVITY: [Isoform 5]: CC Reaction=chloride(in) + 2 hydrogencarbonate(out) + Na(+)(out) = CC chloride(out) + 2 hydrogencarbonate(in) + Na(+)(in); CC Xref=Rhea:RHEA:72739, ChEBI:CHEBI:17544, ChEBI:CHEBI:17996, CC ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:18577713}; CC -!- ACTIVITY REGULATION: [Isoform 1]: Activity is inhibited by 4,4'-Di- CC isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of CC several anion channels and transporters). CC {ECO:0000269|PubMed:18577713}. CC -!- ACTIVITY REGULATION: [Isoform 3]: Activity is inhibited by 4,4'-Di- CC isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of CC several anion channels and transporters). {ECO:0000269|PubMed:11133997, CC ECO:0000269|PubMed:18577713}. CC -!- ACTIVITY REGULATION: [Isoform 4]: Activity is inhibited by 4,4'-Di- CC isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of CC several anion channels and transporters) (PubMed:18577713). Zinc- CC binding negatively regulates its activity (Probable). CC {ECO:0000269|PubMed:18577713, ECO:0000305|PubMed:28935959}. CC -!- ACTIVITY REGULATION: [Isoform 5]: Activity is inhibited by 4,4'-Di- CC isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of CC several anion channels and transporters). CC {ECO:0000269|PubMed:18577713}. CC -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q6RVG2}. CC -!- SUBUNIT: [Isoform 4]: Homodimer. {ECO:0000269|PubMed:15489334}. CC -!- SUBCELLULAR LOCATION: Apical cell membrane CC {ECO:0000269|PubMed:17715183}; Multi-pass membrane protein CC {ECO:0000255}. Basolateral cell membrane CC {ECO:0000250|UniProtKB:Q6RVG2}; Multi-pass membrane protein CC {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle CC membrane {ECO:0000250|UniProtKB:Q6RVG2}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane CC {ECO:0000269|PubMed:18577713}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell membrane CC {ECO:0000269|PubMed:18577713}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- SUBCELLULAR LOCATION: [Isoform 4]: Cell membrane CC {ECO:0000269|PubMed:18577713}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- SUBCELLULAR LOCATION: [Isoform 5]: Cell membrane CC {ECO:0000269|PubMed:18577713}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=8; CC Name=1 {ECO:0000269|PubMed:18577713}; Synonyms=NDCBE-A CC {ECO:0000303|PubMed:18577713}; CC IsoId=Q2Y0W8-1; Sequence=Displayed; CC Name=2 {ECO:0000269|PubMed:9872452}; CC IsoId=Q2Y0W8-2; Sequence=VSP_052760, VSP_052765; CC Name=3 {ECO:0000269|PubMed:11133997}; Synonyms=NDCBE-B CC {ECO:0000303|PubMed:18577713}; CC IsoId=Q2Y0W8-3; Sequence=VSP_052765; CC Name=4 {ECO:0000269|PubMed:11133997}; Synonyms=NDCBE-D CC {ECO:0000303|PubMed:18577713}; CC IsoId=Q2Y0W8-4; Sequence=VSP_052759, VSP_052765; CC Name=5 {ECO:0000269|PubMed:18577713}; Synonyms=NDCBE-C CC {ECO:0000303|PubMed:18577713}; CC IsoId=Q2Y0W8-5; Sequence=VSP_052759; CC Name=6 {ECO:0000269|PubMed:15489334}; CC IsoId=Q2Y0W8-6; Sequence=VSP_052761, VSP_052762; CC Name=7; CC IsoId=Q2Y0W8-7; Sequence=VSP_052759, VSP_052763, VSP_052764; CC Name=8; CC IsoId=Q2Y0W8-8; Sequence=VSP_052759, VSP_052761, VSP_052762; CC -!- TISSUE SPECIFICITY: Expressed in the pyramidal cells of the hippocampus CC (at protein level). Highly expressed in all major regions of the brain, CC spinal column and in testis, and moderate levels in trachea, thyroid CC and medulla region of kidney. Low expression levels observed in CC pancreas and kidney cortex. {ECO:0000269|PubMed:10362779, CC ECO:0000269|PubMed:11133997, ECO:0000269|PubMed:17715183}. CC -!- TISSUE SPECIFICITY: [Isoform 1]: Expressed in the brain. CC {ECO:0000269|PubMed:18577713}. CC -!- TISSUE SPECIFICITY: [Isoform 4]: Expressed in the brain, heart and CC kidney. {ECO:0000269|PubMed:18577713}. CC -!- TISSUE SPECIFICITY: [Isoform 5]: Expressed in the brain, heart and CC kidney. {ECO:0000269|PubMed:18577713}. CC -!- MISCELLANEOUS: [Isoform 3]: May be due to an intron retention. CC {ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform 4]: May be due to an intron retention. CC {ECO:0000305}. CC -!- SIMILARITY: Belongs to the anion exchanger (TC 2.A.31) family. CC {ECO:0000255}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA34459.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=CAD38576.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF069512; AAC82380.1; -; mRNA. DR EMBL; DQ063579; AAY79176.1; -; mRNA. DR EMBL; DQ975204; ABJ09587.1; -; mRNA. DR EMBL; DQ996537; ABJ91576.1; -; mRNA. DR EMBL; DQ996398; ABJ91577.1; -; mRNA. DR EMBL; AB018282; BAA34459.1; ALT_INIT; mRNA. DR EMBL; AK295315; BAG58292.1; -; mRNA. DR EMBL; AL831915; CAD38576.2; ALT_INIT; mRNA. DR EMBL; AC025097; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC046135; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC107031; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471111; EAW58192.1; -; Genomic_DNA. DR EMBL; BC025994; AAH25994.1; -; mRNA. DR EMBL; AF107099; AAD52981.1; -; mRNA. DR CCDS; CCDS44890.1; -. [Q2Y0W8-1] DR CCDS; CCDS58232.1; -. [Q2Y0W8-7] DR CCDS; CCDS58233.1; -. [Q2Y0W8-8] DR CCDS; CCDS73470.1; -. [Q2Y0W8-5] DR RefSeq; NP_001035049.1; NM_001039960.2. [Q2Y0W8-1] DR RefSeq; NP_001245330.1; NM_001258401.2. [Q2Y0W8-5] DR RefSeq; NP_001245331.1; NM_001258402.1. [Q2Y0W8-6] DR RefSeq; NP_001245332.1; NM_001258403.1. [Q2Y0W8-7] DR RefSeq; NP_001254544.1; NM_001267615.1. [Q2Y0W8-8] DR RefSeq; XP_016875730.1; XM_017020241.1. DR PDB; 5JHO; X-ray; 2.80 A; A/B=54-397. DR PDBsum; 5JHO; -. DR AlphaFoldDB; Q2Y0W8; -. DR SMR; Q2Y0W8; -. DR BioGRID; 114877; 35. DR IntAct; Q2Y0W8; 30. DR STRING; 9606.ENSP00000405812; -. DR DrugBank; DB01390; Sodium bicarbonate. DR TCDB; 2.A.31.2.4; the anion exchanger (ae) family. DR GlyGen; Q2Y0W8; 1 site. DR iPTMnet; Q2Y0W8; -. DR PhosphoSitePlus; Q2Y0W8; -. DR SwissPalm; Q2Y0W8; -. DR BioMuta; SLC4A8; -. DR DMDM; 121942008; -. DR EPD; Q2Y0W8; -. DR jPOST; Q2Y0W8; -. DR MassIVE; Q2Y0W8; -. DR MaxQB; Q2Y0W8; -. DR PaxDb; 9606-ENSP00000405812; -. DR PeptideAtlas; Q2Y0W8; -. DR ProteomicsDB; 16963; -. DR ProteomicsDB; 24921; -. DR ProteomicsDB; 61540; -. [Q2Y0W8-1] DR ProteomicsDB; 61541; -. [Q2Y0W8-2] DR ProteomicsDB; 61542; -. [Q2Y0W8-3] DR ProteomicsDB; 61543; -. [Q2Y0W8-4] DR ProteomicsDB; 61544; -. [Q2Y0W8-5] DR ProteomicsDB; 61545; -. [Q2Y0W8-6] DR ProteomicsDB; 61546; -. [Q2Y0W8-7] DR Antibodypedia; 26410; 193 antibodies from 25 providers. DR DNASU; 9498; -. DR Ensembl; ENST00000358657.7; ENSP00000351483.4; ENSG00000050438.17. [Q2Y0W8-5] DR Ensembl; ENST00000453097.7; ENSP00000405812.2; ENSG00000050438.17. [Q2Y0W8-1] DR Ensembl; ENST00000514353.7; ENSP00000442561.2; ENSG00000050438.17. [Q2Y0W8-7] DR Ensembl; ENST00000535225.6; ENSP00000441520.1; ENSG00000050438.17. [Q2Y0W8-8] DR GeneID; 9498; -. DR KEGG; hsa:9498; -. DR MANE-Select; ENST00000453097.7; ENSP00000405812.2; NM_001039960.3; NP_001035049.1. DR UCSC; uc001rys.3; human. [Q2Y0W8-1] DR AGR; HGNC:11034; -. DR CTD; 9498; -. DR DisGeNET; 9498; -. DR GeneCards; SLC4A8; -. DR HGNC; HGNC:11034; SLC4A8. DR HPA; ENSG00000050438; Group enriched (brain, pituitary gland, retina, testis). DR MIM; 605024; gene. DR neXtProt; NX_Q2Y0W8; -. DR OpenTargets; ENSG00000050438; -. DR PharmGKB; PA35900; -. DR VEuPathDB; HostDB:ENSG00000050438; -. DR eggNOG; KOG1172; Eukaryota. DR GeneTree; ENSGT00940000157422; -. DR HOGENOM; CLU_002289_5_3_1; -. DR InParanoid; Q2Y0W8; -. DR OMA; VCHIEAE; -. DR OrthoDB; 1013180at2759; -. DR PhylomeDB; Q2Y0W8; -. DR TreeFam; TF313630; -. DR PathwayCommons; Q2Y0W8; -. DR Reactome; R-HSA-425381; Bicarbonate transporters. DR SignaLink; Q2Y0W8; -. DR SIGNOR; Q2Y0W8; -. DR BioGRID-ORCS; 9498; 17 hits in 1150 CRISPR screens. DR ChiTaRS; SLC4A8; human. DR GeneWiki; SLC4A8; -. DR GenomeRNAi; 9498; -. DR Pharos; Q2Y0W8; Tbio. DR PRO; PR:Q2Y0W8; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q2Y0W8; Protein. DR Bgee; ENSG00000050438; Expressed in pons and 168 other cell types or tissues. DR GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0032279; C:asymmetric synapse; ISS:ARUK-UCL. DR GO; GO:0043679; C:axon terminus; ISS:ARUK-UCL. DR GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0030425; C:dendrite; IDA:ARUK-UCL. DR GO; GO:0097386; C:glial cell projection; ISS:ARUK-UCL. DR GO; GO:0098978; C:glutamatergic synapse; ISS:ARUK-UCL. DR GO; GO:0097457; C:hippocampal mossy fiber; ISS:ARUK-UCL. DR GO; GO:0016020; C:membrane; ISS:ARUK-UCL. DR GO; GO:0043005; C:neuron projection; ISS:ARUK-UCL. DR GO; GO:0032809; C:neuronal cell body membrane; ISS:ARUK-UCL. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0098793; C:presynapse; ISS:ARUK-UCL. DR GO; GO:0042734; C:presynaptic membrane; ISS:ARUK-UCL. DR GO; GO:0032280; C:symmetric synapse; ISS:ARUK-UCL. DR GO; GO:0008021; C:synaptic vesicle; ISS:ARUK-UCL. DR GO; GO:0030672; C:synaptic vesicle membrane; IEA:UniProtKB-SubCell. DR GO; GO:0043195; C:terminal bouton; ISS:ARUK-UCL. DR GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:ARUK-UCL. DR GO; GO:0015108; F:chloride transmembrane transporter activity; IDA:ARUK-UCL. DR GO; GO:0042802; F:identical protein binding; IDA:UniProtKB. DR GO; GO:0015081; F:sodium ion transmembrane transporter activity; IDA:ARUK-UCL. DR GO; GO:0140892; F:sodium,bicarbonate:chloride antiporter activity; IDA:UniProtKB. DR GO; GO:0008510; F:sodium:bicarbonate symporter activity; IDA:ARUK-UCL. DR GO; GO:0005452; F:solute:inorganic anion antiporter activity; TAS:Reactome. DR GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB. DR GO; GO:0110010; P:basolateral protein secretion; IEA:Ensembl. DR GO; GO:0015701; P:bicarbonate transport; IDA:ARUK-UCL. DR GO; GO:1902476; P:chloride transmembrane transport; IDA:ARUK-UCL. DR GO; GO:0050804; P:modulation of chemical synaptic transmission; ISS:ARUK-UCL. DR GO; GO:2000302; P:positive regulation of synaptic vesicle exocytosis; ISS:ARUK-UCL. DR GO; GO:0051453; P:regulation of intracellular pH; IDA:ARUK-UCL. DR GO; GO:0042391; P:regulation of membrane potential; IDA:ARUK-UCL. DR GO; GO:0035725; P:sodium ion transmembrane transport; IDA:ARUK-UCL. DR GO; GO:0055085; P:transmembrane transport; IBA:GO_Central. DR GO; GO:0150104; P:transport across blood-brain barrier; NAS:ARUK-UCL. DR Gene3D; 1.10.287.570; Helical hairpin bin; 1. DR InterPro; IPR013769; Band3_cytoplasmic_dom. DR InterPro; IPR011531; HCO3_transpt-like_TM_dom. DR InterPro; IPR003020; HCO3_transpt_euk. DR InterPro; IPR003024; Na/HCO3_transpt. DR InterPro; IPR016152; PTrfase/Anion_transptr. DR NCBIfam; TIGR00834; ae; 1. DR PANTHER; PTHR11453; ANION EXCHANGE PROTEIN; 1. DR PANTHER; PTHR11453:SF37; ELECTRONEUTRAL SODIUM BICARBONATE EXCHANGER 1; 1. DR Pfam; PF07565; Band_3_cyto; 1. DR Pfam; PF00955; HCO3_cotransp; 1. DR PRINTS; PR01231; HCO3TRNSPORT. DR PRINTS; PR01232; NAHCO3TRSPRT. DR SUPFAM; SSF55804; Phoshotransferase/anion transport protein; 1. DR Genevisible; Q2Y0W8; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Anion exchange; Antiport; KW Cell membrane; Coiled coil; Cytoplasmic vesicle; Disulfide bond; KW Glycoprotein; Ion transport; Membrane; Reference proteome; Sodium; KW Sodium transport; Synapse; Transmembrane; Transmembrane helix; Transport; KW Zinc. FT CHAIN 1..1093 FT /note="Electroneutral sodium bicarbonate exchanger 1" FT /id="PRO_0000328922" FT TOPO_DOM 1..478 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 479..499 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 500..523 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 524..544 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 545..565 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 566..586 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 587..595 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 596..616 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 617..687 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 688..708 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 709..731 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 732..752 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 753..778 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 779..799 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 800..824 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 825..845 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 846..881 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 882..902 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 903..904 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 905..925 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 926..962 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 963..983 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 984..1093 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 1..25 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 55..95 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 1010..1036 FT /evidence="ECO:0000255" FT COMPBIAS 57..77 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CARBOHYD 646 FT /note="N-linked (GlcNAc) asparagine" FT /evidence="ECO:0000250|UniProtKB:Q6RVG2" FT DISULFID 636..684 FT /evidence="ECO:0000250|UniProtKB:Q6RVG2" FT DISULFID 638..672 FT /evidence="ECO:0000250|UniProtKB:Q6RVG2" FT VAR_SEQ 1..53 FT /note="Missing (in isoform 4, isoform 5, isoform 7 and FT isoform 8)" FT /evidence="ECO:0000303|PubMed:14702039, FT ECO:0000303|PubMed:17974005, ECO:0000303|PubMed:18577713" FT /id="VSP_052759" FT VAR_SEQ 1..16 FT /note="MPAAGSNEPDGVLSYQ -> MFNKNNSNKLRSTPRYRRGDPGYLNFTELGPL FT KPEQKDQWSQH (in isoform 2)" FT /evidence="ECO:0000303|PubMed:9872452" FT /id="VSP_052760" FT VAR_SEQ 671..691 FT /note="ECQEMHGEFMGSACGHHGPYT -> VSLGAARCPSIVTTGLGGTSK (in FT isoform 6 and isoform 8)" FT /evidence="ECO:0000303|PubMed:14702039, FT ECO:0000303|PubMed:15489334" FT /id="VSP_052761" FT VAR_SEQ 692..1093 FT /note="Missing (in isoform 6 and isoform 8)" FT /evidence="ECO:0000303|PubMed:14702039, FT ECO:0000303|PubMed:15489334" FT /id="VSP_052762" FT VAR_SEQ 725..800 FT /note="VRSMVSDFAVFLTIFTMVIIDFLIGVPSPKLQVPSVFKPTRDDRGWIINPIG FT PNPWWTVIAAIIPALLCTILIFMD -> MESCSVAWLECGGVILAHCNLRLLPSSWDYR FT HAPPQPANFCIFSRDGVSPCWPGWSQSLDLVICLPRPPKMLGLQA (in isoform FT 7)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_052763" FT VAR_SEQ 801..1093 FT /note="Missing (in isoform 7)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_052764" FT VAR_SEQ 1028..1093 FT /note="EAEKMLEIGGDKFPLESRKLLSSPGKNISCRCDPSEINISDEMPKTTVWKAL FT SMNSGNAKEKSLFN -> VIVLAPTVYLGASNYRT (in isoform 2, isoform FT 3 and isoform 4)" FT /evidence="ECO:0000303|PubMed:11133997, FT ECO:0000303|PubMed:18577713, ECO:0000303|PubMed:9872452" FT /id="VSP_052765" FT VARIANT 312 FT /note="D -> A (in dbSNP:rs35966334)" FT /id="VAR_048351" FT VARIANT 898 FT /note="I -> V (in dbSNP:rs12318785)" FT /id="VAR_048352" FT CONFLICT 482 FT /note="F -> L (in Ref. 4; BAG58292)" FT /evidence="ECO:0000305" FT CONFLICT 1008 FT /note="M -> T (in Ref. 1; AAC82380)" FT /evidence="ECO:0000305" FT HELIX 98..104 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 116..125 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 133..147 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 148..150 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 163..175 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 176..182 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 187..195 FT /evidence="ECO:0007829|PDB:5JHO" FT TURN 198..201 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 202..204 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 206..216 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 291..293 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 299..308 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 315..325 FT /evidence="ECO:0007829|PDB:5JHO" FT TURN 328..330 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 331..333 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 337..345 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 350..363 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 367..375 FT /evidence="ECO:0007829|PDB:5JHO" FT HELIX 379..392 FT /evidence="ECO:0007829|PDB:5JHO" FT STRAND 394..396 FT /evidence="ECO:0007829|PDB:5JHO" FT MOTIF Q2Y0W8-4:340..344 FT /note="VTVLP; mediates dimerization" FT /evidence="ECO:0000269|PubMed:28935959" FT BINDING Q2Y0W8-4:167 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000305|PubMed:28935959" FT BINDING Q2Y0W8-4:169 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000305|PubMed:28935959" FT MUTAGEN Q2Y0W8-4:80 FT /note="W->F: Significant reduction in zinc binding." FT /evidence="ECO:0000269|PubMed:28935959" FT MUTAGEN Q2Y0W8-4:167 FT /note="H->A: Significant reduction in zinc binding." FT /evidence="ECO:0000269|PubMed:28935959" FT MUTAGEN Q2Y0W8-4:169 FT /note="H->A: Significant reduction in zinc binding." FT /evidence="ECO:0000269|PubMed:28935959" FT CONFLICT Q2Y0W8-7:707 FT /note="Q -> R (in Ref. 5; CAD38576)" FT /evidence="ECO:0000305" FT CONFLICT Q2Y0W8-7:716 FT /note="R -> G (in Ref. 5; CAD38576)" FT /evidence="ECO:0000305" SQ SEQUENCE 1093 AA; 122938 MW; DDF9D0BC3CBD1A06 CRC64; MPAAGSNEPD GVLSYQRPDE EAVVDQGGTS TILNIHYEKE ELEGHRTLYV GVRMPLGRQS HRHHRTHGQK HRRRGRGKGA SQGEEGLEAL AHDTPSQRVQ FILGTEEDEE HVPHELFTEL DEICMKEGED AEWKETARWL KFEEDVEDGG ERWSKPYVAT LSLHSLFELR SCLINGTVLL DMHANSIEEI SDLILDQQEL SSDLNDSMRV KVREALLKKH HHQNEKKRNN LIPIVRSFAE VGKKQSDPHL MDKHGQTVSP QSVPTTNLEV KNGVNCEHSP VDLSKVDLHF MKKIPTGAEA SNVLVGEVDI LDRPIVAFVR LSPAVLLSGL TEVPIPTRFL FILLGPVGKG QQYHEIGRSM ATIMTDEIFH DVAYKAKERD DLLAGIDEFL DQVTVLPPGE WDPSIRIEPP KNVPSQEKRK MPGVPNGNVC HIEQEPHGGH SGPELQRTGR LFGGLVLDIK RKAPWYWSDY RDALSLQCLA SFLFLYCACM SPVITFGGLL GEATEGRISA IESLFGASMT GIAYSLFAGQ ALTILGSTGP VLVFEKILFK FCKDYALSYL SLRACIGLWT AFLCIVLVAT DASSLVCYIT RFTEEAFASL ICIIFIYEAI EKLIHLAETY PIHMHSQLDH LSLYYCRCTL PENPNNHTLQ YWKDHNIVTA EVHWANLTVS ECQEMHGEFM GSACGHHGPY TPDVLFWSCI LFFTTFILSS TLKTFKTSRY FPTRVRSMVS DFAVFLTIFT MVIIDFLIGV PSPKLQVPSV FKPTRDDRGW IINPIGPNPW WTVIAAIIPA LLCTILIFMD QQITAVIINR KEHKLKKGCG YHLDLLMVAI MLGVCSIMGL PWFVAATVLS ITHVNSLKLE SECSAPGEQP KFLGIREQRV TGLMIFVLMG CSVFMTAILK FIPMPVLYGV FLYMGVSSLQ GIQFFDRLKL FGMPAKHQPD FIYLRHVPLR KVHLFTLIQL TCLVLLWVIK ASPAAIVFPM MVLALVFVRK VMDLCFSKRE LSWLDDLMPE SKKKKLDDAK KKAKEEEEAE KMLEIGGDKF PLESRKLLSS PGKNISCRCD PSEINISDEM PKTTVWKALS MNSGNAKEKS LFN //